Canada is well placed to approve Pfizer and BioNTech’s COVID-19 vaccine soon – after which it can be delivered to the country very quickly, says a BioNTech executive.
“If I use the UK as an example, we got acceptance at 1am. We accepted [the] the vaccine was released and shipped within 24 hours, ”said Sean Marett, Germany’s head of business and trade at BioNTech, in partnership with Pfizer in the US, to develop one of the most promising COVID-19 vaccines in the world.
“Certainly, from the discussions we’ve had, Canada is in a good position to approve the vaccine soon,” Marette told CBC chief political correspondent Rosemary Barton on Sunday.
The Pfizer / BioNTech product – which recently had a green light in the UK for emergency use – could receive Health Canada approval this coming week. Health regulators are examining three other vaccines created by Moderna, AstraZeneca and Jannsen.
“Once approved, we release the vaccine and then send it out. We’ve already produced the vaccine and saved the doses for Canada,” Marett said. Rosemary Barton Live.
Adoption of the regulations is a key step before implementing the specific details of the federal government’s expansion plan.
“We are negotiating more specific delivery dates pending Health Canada’s approval,” Procurement Minister Anita Anand told CBC’s Vassy Kapelos earlier this week. “That’s why we’re putting logistics systems in place so that time is not lost between acceptance and distribution to provinces and territories.”
Marette called the vaccine distribution plan a “biological equivalent of the moon.”
“You have to do everything right, which of course includes time,” Marette said, when asked about specific delivery dates. “These things … tend to move [for] a few days. But so far, with our experience with a country, the UK, we’ve seen things move pretty well. ”